IQVIA HOLDINGS INC. Common Stock and Additional Paid-In Capital
IQVIA HOLDINGS INC. (IQV) had Common Stock and Additional Paid-In Capital of $11.40 billion as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2026-05-05
- 2026-03-31: Common Stocks, Including Additional Paid in Capital $11.40B.
- 2025-12-31: Common Stocks, Including Additional Paid in Capital $11.38B.
- 2025-09-30: Common Stocks, Including Additional Paid in Capital $11.32B.
- 2025-06-30: Common Stocks, Including Additional Paid in Capital $11.22B.
| Period end | Common Stocks, Including Additional Paid in Capital | Common Stocks, Including Additional Paid in Capital as first filed |
|---|---|---|
| 2026-03-31 | $11.40B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $11.38B 10-Q · filed 2026-05-05 | |
| 2025-09-30 | $11.32B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $11.22B 10-Q · filed 2025-07-22 | |
| 2025-03-31 | $11.17B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $11.14B 10-K · filed 2026-02-17 | |
| 2024-09-30 | $11.11B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $11.06B 10-Q · filed 2024-07-22 | |
| 2024-03-31 | $11.02B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $11.03B 10-K · filed 2025-02-13 | |
| 2023-09-30 | $10.99B 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $10.95B 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $10.91B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $10.90B 10-K · filed 2024-02-15 | |
| 2022-09-30 | $10.85B 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $10.79B 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $10.74B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $10.78B 10-K · filed 2023-02-15 | |
| 2021-09-30 | $10.75B 10-Q · filed 2021-10-22 | |
| 2021-06-30 | $10.70B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $11.07B 10-Q · filed 2021-04-23 | |
| 2020-12-31 | $11.10B 10-K · filed 2022-02-16 | |
| 2020-09-30 | $11.07B 10-Q · filed 2020-10-22 | |
| 2020-06-30 | $11.04B 10-Q · filed 2020-07-23 | |
| 2020-03-31 | $11.01B 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $11.05B 10-K · filed 2021-02-12 | |
| 2019-09-30 | $10.99B 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $10.96B 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $10.93B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $10.90B 10-K · filed 2020-02-18 | |
| 2018-09-30 | $10.88B 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $10.84B 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $10.80B 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $10.78B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $10.76B 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $10.72B 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $10.66B 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $10.60B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $48.76M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.19M 10-Q · filed 2016-07-27 | |
| 2016-03-31 | $25.91M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $9.00M 10-K · filed 2017-02-16 | $8.78M 10-K · filed 2016-02-11 |
| 2015-09-30 | $239.59M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | $28.52M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $178.97M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $143.83M 10-K · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |